N-Phenethyl-4-piperidinone
N-Phenethyl-4-piperidinone (NPP) is a derivative of 4-piperidinone with the molecular formula C13H17NO. 4-Piperidinone is used as an intermediate in the manufacture of chemicals and pharmaceutical drugs such as fentanyl.
Names | |
---|---|
Preferred IUPAC name
1-(2-Phenylethyl)piperidin-4-one | |
Other names
1-Phenethylpiperidin-4-one (no longer recommended) N-Phenylethyl-4-piperidinone N-Phenethyl-4-piperidone | |
Identifiers | |
3D model (JSmol) |
|
Abbreviations | NPP |
ChemSpider | |
ECHA InfoCard | 100.049.630 |
PubChem CID |
|
UNII | |
CompTox Dashboard (EPA) |
|
| |
| |
Properties | |
C13H17NO | |
Molar mass | 203.28 g/mol |
Density | 1.057 g/cm3 |
Melting point | 56 to 60 °C (133 to 140 °F; 329 to 333 K) |
Hazards | |
EU classification (DSD) (outdated) |
Flammable (F) Harmful (Xn) Dangerous for the environment (N) |
NFPA 704 (fire diamond) | |
Legal status |
|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
Infobox references | |
Because of its possible use in the illicit manufacture of fentanyl, NPP was placed onto the list of controlled chemicals in the USA in 2007, and possession and sales of this compound are now restricted.
Preparation
N-Phenethyl-4-piperidinone can be prepared from 4-piperidinone and phenethyl bromide in biphasic conditions with a variety of phase transfer catalysts.
Uses
N-Phenethyl-4-piperidinone is useful in the synthesis of pharmaceuticals, primarily fentanyl and its analogs. Paul Janssen (founder of Janssen Pharmaceutica) first synthesized fentanyl in 1960 from NPP.[1] Janssen's synthesis involved reacting N-Phenethyl-4-piperidinone with aniline, and then reducing the imine product with sodium borohydride to 4-anilino-N-phenethylpiperidine (ANPP). This product is reacted with propionyl chloride to form fentanyl.
References
- William Schulz. "Fentanyl". Chemical & Engineering News.
External links
- Beckett, A. H.; Casy, A. F.; Kirk, G. (1959). "Alpha- and Beta-Prodine Type Compounds". Journal of Medicinal Chemistry. 1 (1): 37–58. doi:10.1021/jm50002a004. PMID 13655028.